Together, these findings indicate that V␣14͞V8.2 is a unique antigen receptor for NKT cells but not for conventional T cells. Because V␣14 NKT cell development was inhibited largely in mice that lack the MHC class I-like molecule CD1d, positive selection of V␣14-expressing immature NKT cells requires CD1d expression (14,15). Recently, it has been shown that glycolipid, ␣-galactosylceramide (␣-GalCer), and glycosylphosphatidylinositol-anchored proteins can be presented by murine CD1d (13, 16). Subsequently, it was demonstrated that NKT cells can recognize cellular lipids or purified phospholipids distinct from ␣-GalCer (17).Although physiological functions of NKT cells remain obscure, some studies have suggested that NKT cells can control autoimmune diseases (18-21) and Th1͞Th2 cell development Here, we have evaluated the role of V␣14 NKT cells in allograft rejection and tolerance by using a murine model of transplantation. We found that V␣14 NKT cells play a critical role in the induction of vascularized cardiac allograft tolerance by blockade of lymphocyte function-associated antigen-1 (LFA-1)͞intercellular adhesion molecule-1 (ICAM-1) or CD28͞B7 interactions. Possible mechanisms for the tolerogenic function of V␣14 NKT cells are examined.
Materials and Methods mAbs and Reagents.Hybridomas producing anti-LFA-1 and anti-ICAM-1 mAbs (KBA and KAT-1, respectively) were described previously (32, 33). Hybridomas producing anti-B7-1 and anti-B7-2 mAbs (1G10 and GL1, respectively) were purchased from American Type Culture Collection (ATCC). Hybridoma producing anti-IL-4 mAb (11B11) also was purchased from ATCC. These mAbs were purified from ascites by using protein G column. mAbs against CD1d (1B1) and H-2K b (AF6-88.5, FITC-labeled) were purchased from PharMingen. An annexin V PE staining kit was purchased from PharMingen.